CDK inhibitor targets: a hit or miss proposition? Cyclin-dependent kinase inhibitors kill tumor cells by downregulation of anti-apoptotic proteins

被引：4
作者：
Dai, Y
Grant, S
机构：
[1] Virginia Commonwealth Univ, Massey Canc Ctr, Div Hematol Oncol, Richmond, VA USA
[2] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Med, Richmond, VA USA
[3] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Biochem & Pharmacol, Richmond, VA USA
来源：
CANCER BIOLOGY & THERAPY | 2006年 / 5卷 / 02期
关键词：
cyclin-dependent kinases; CDK inhibitors; anti-apoptotic proteins; transcriptional regulation; apoptosis;
D O I：
10.4161/cbt.5.2.2568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：171 / 173
页数：3
相关论文
共 5 条
[1]   A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival [J].
Alvi, AJ ;
Austen, B ;
Weston, VJ ;
Fegan, C ;
MacCallum, D ;
Gianella-Borradori, A ;
Lane, DP ;
Hubank, M ;
Powell, JE ;
Wei, WB ;
Taylor, AMR ;
Moss, PAH ;
Stankovic, T .
BLOOD, 2005, 105 (11) :4484-4491
[2]   Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo [J].
Chao, SH ;
Price, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :31793-31799
[3]   Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death [J].
Chen, R ;
Keating, MJ ;
Gandhi, V ;
Plunkett, W .
BLOOD, 2005, 106 (07) :2513-2519
[4]   Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: A review [J].
Singhal, S ;
Vachani, A ;
Antin-Ozerkis, D ;
Kaiser, LR ;
Albelda, SM .
CLINICAL CANCER RESEARCH, 2005, 11 (11) :3974-3986
[5]   Proliferation of cancer cells despite CDK2 inhibition [J].
Tetsu, O ;
McCormick, F .
CANCER CELL, 2003, 3 (03) :233-245
1